Beacon Group has announced the appointment of Dr Rajesh Patel as its Group CEO, effective April 1, 2026. Dr Rajesh Patel brings with him 36 years of extensive industry experience and a strong track record of leadership in the healthcare sector.
Over the course of his distinguished career, he has built deep expertise in sales, marketing, business development, strategic growth, and operational excellence, with significant contributions across the healthcare and diagnostics industry.
As Group CEO, Dr Rajesh Patel will lead the business operations of all three companies of Beacon Group - Beacon Diagnostics, Vector Biotek, and Biogeny Diagnostics - in alignment with the Group’s strategic vision and in close coordination with their respective CEOs.
He will be responsible for driving the Group’s strategic direction, strengthening cross-company synergies, accelerating market expansion, and enhancing organisational capability across the businesses.
